Publicaciones científicas en Inglés. 2021

Bhatt DL, Kaski JC, Delaney S, Alasnag M, Andreotti F, Angiolillo DJ, Ferro A, Gorog DA, Lorenzatti AJ, Mamas M, McNeil J, Nicolau JC, Steg PG, Tamargo J, Tan D, Valgimigli M.
Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention
Int J Cardiol. 2021 Aug 15;337:1-8. doi: 10.1016/j.ijcard.2021.05.012. Epub 2021 May 15. PMID: 34000356. Format:

Drexel H, Pocock SJ, Lewis BS, Saely CH, Kaski JC, Rosano GMC, Tautermann G, Huber K, Dopheide JF, Mader A, Niessner A, Savarese G, Schmidt TA, Semb AG, Tamargo J, Wassmann S, Clodi M, Kjeldsen KP, Agewall S.
Subgroup analyses in randomized clinical trials: Value and limitations Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy. Eur Heart J Cardiovasc Pharmacother
2021 Jun 28:pvab048. doi: 10.1093/ehjcvp/pvab048. Epub ahead of print. PMID: 34180504.

Krogager ML, Kragholm K, Thomassen JQ, Søgaard P, Lewis BS, Wassmann S, Baumgartner I, Ceconi C, Schmidt TA, Kaski JC, Drexel H, Semb AG, Agewall S, Niessner A, Savarese G, Kjeldsen KP, Borghi C, Tamargo J, Torp-Pedersen C.
Update on management of hypokalemia and goals for the lower potassium level in patients with cardiovascular disease: A review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother. 2021 May 6:pvab038. doi: 10.1093/ehjcvp/pvab038. Epub ahead of print. PMID: 33956964.

Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ.
The Role of Pharmacogenomics in Contemporary Cardiovascular Therapy: A position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Cardiovasc Pharmacother. 2021 Feb 26:pvab018. doi: 10.1093/ehjcvp/pvab018. Epub ahead of print. PMID: 33638977.

Tamargo J, Agewall S.
Fluoroquinolone use and valvular heart disease: is the jury still out?
Eur Heart J. 2021 Aug 7;42(30):2909-2911. doi: 10.1093/eurheartj/ehab426. PMID: 34254116.

Varona M, Coll-Vinent B, Martín A, Carbajosa J, Sánchez J, Tamargo J, Cancio M, Sánchez S, Del Arco C, Ríos J, Fernández-Simón A, Ormaetxe JM, Suero C; EMERG-AF investigators (Appendix 1).
Factors associated with poor prognosis in patients with atrial fibrillation: An emergency department perspective the EMERG-AF study.
Am J Emerg Med. 2021 Jul 31;50:270-277. doi: 10.1016/j.ajem.2021.07.055. Epub ahead of print. PMID: 34418718.

Coll-Vinent B, Varona M, Martin A, Carbajosa J, Sánchez J, Tamargo J, Cancio M, Sánchez S, Del Arco C, Miró Ò, Ríos J, García A, Fernández-Simón A, Miota N, Suero C; EMERG-AF investigators (Appendix 1).
Association between acute heart failure and major cardiovascular events in atrial fibrillation patients presenting at the emergency department: an EMERG-AF ancillary study
Eur J Emerg Med. 2021 Jun 1;28(3):210-217.

Ruilope LM, Ruiz-Hurtado G, Tamargo J.
Adequate blood pressure control unattainable without adequate recognition and treatment of primary aldosteronism
Trends Cardiovasc Med. 2021 Apr 16:S1050-1738.

Nieto-Marín P, Tinaquero D, Utrilla RG, Cebrián J, González-Guerra A, Crespo-García T, Cámara-Checa A, Rubio-Alarcón M, Dago M, Alfayate S, Filgueiras D, Peinado R, López-Sendón JL, Jalife J, Tamargo J, Bernal JA, Caballero R, Delpón E; I T A C A Consortium Investigators.
Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome
Cardiovasc Res. 2021 Feb 8:cvab045. doi: 10.1093/cvr/cvab045.

González-Juanatey JR, Tamargo J, Torres F, Weisser B, Oudovenko N.
Pharmacodynamic study of the cardiovascular polypill. Is there any interaction among the monocomponents?
Rev Esp Cardiol (Engl Ed). 2021 Jan;74(1):51-58. English, Spanish. doi: 10.1016/j.rec.2019.11.008. Epub 2020 Jan 23. PMID: 31983653.

Tamargo J, Caballero R, Delpón E.
Sex-related differences in the pharmacological treatment of heart failure
Pharmacol Ther. 2021 May 13:107891. doi: 10.1016/j.pharmthera.2021.107891. Epub ahead of print. PMID: 33992681.

Tamargo J.
Does anticoagulation reduce mortality in patients with atrial fibrillation who later developed a COVID-19 infection?
Int J Cardiol. 2021 May 15;331:340-341. doi: 10.1016/j.ijcard.2021.01.019. Epub 2021 Jan 27. PMID: 33515615; PMCID: PMC7839803.

Tamargo J, Caballero R, Delpón E.
The pharmacotherapeutic management of hyperkalemia in patients with cardiovascular disease.
Expert Opin Pharmacother. 2021 Apr 21;1-23. doi: 10.1080/14656566.2021.1891223 PMID: 33620275.

Martín García M, Mitroi C, Mazón P, Gacía Sanz R, Virizuela JA, Arenas M, Egocheaga I, et al.
Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC.
Rev Esp Cardiol. 2021 [In press] https://doi.org/10.1016/j.recesp.2020.11.014